102 related articles for article (PubMed ID: 23091851)
41. [Relationships between serum lipid composition and acetylator status as markers of energy metabolism in women with coronary heart disease, metabolic syndrome, and type 2 diabetes mellitus].
Matveeva SA
Ter Arkh; 2013; 85(12):14-20. PubMed ID: 24640662
[TBL] [Abstract][Full Text] [Related]
42. [Primary preventive effect of metformin upon atherosclerosis in patients with type 2 diabetes mellitus].
Zhang XY; Du JL; Jia YJ; Bai R; Yang Y; Ba Y; Xing Q; Men LL
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2134-7. PubMed ID: 20058619
[TBL] [Abstract][Full Text] [Related]
43. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
[TBL] [Abstract][Full Text] [Related]
44. [Effect of metformin on the expression of tumor necrosis factor-α, Toll like receptors 2/4 and C reactive protein in obese type-2 diabetic patients].
Andrews M; Soto N; Arredondo M
Rev Med Chil; 2012 Nov; 140(11):1377-82. PubMed ID: 23677182
[TBL] [Abstract][Full Text] [Related]
45. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
Nieuwdorp M; Stroes ES; Kastelein JJ;
Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
[TBL] [Abstract][Full Text] [Related]
46. [Clinical effectiveness of metformin and ramipril combination in complex therapy of patients with metabolic syndrome].
Savchenko LH; Kaĭdasheva EI; Kutsenko LO; Kutsenko NL; Hordyns'ka IL; Mamontova TV; Markina TM; Kaĭdashev IP
Lik Sprava; 2013; (1):109-17. PubMed ID: 23951921
[TBL] [Abstract][Full Text] [Related]
47. The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion.
Borowska M; Dworacka M; Wesołowska A; Winiarska H; Krzyżagórska E; Dworacki G
Pharmacology; 2016; 97(3-4):189-94. PubMed ID: 26854669
[TBL] [Abstract][Full Text] [Related]
48. [Characteristics of the therapy of patients with type II diabetes mellitus and metabolic syndrome].
Bodnar PM; Kononenko LO
Lik Sprava; 2000; (7-8):92-4. PubMed ID: 16786661
[TBL] [Abstract][Full Text] [Related]
49. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.
Nasykhova YA; Barbitoff YA; Tonyan ZN; Danilova MM; Nevzorov IA; Komandresova TM; Mikhailova AA; Vasilieva TV; Glavnova OB; Yarmolinskaya MI; Sluchanko EI; Glotov AS
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893047
[TBL] [Abstract][Full Text] [Related]
50. The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects.
Huguenin GV; Rosa G
Br J Nutr; 2010 Aug; 104(4):488-97. PubMed ID: 20420754
[TBL] [Abstract][Full Text] [Related]
51. Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
Tkáč I; Klimčáková L; Javorský M; Fabianová M; Schroner Z; Hermanová H; Babjaková E; Tkáčová R
Diabetes Obes Metab; 2013 Feb; 15(2):189-91. PubMed ID: 22882994
[TBL] [Abstract][Full Text] [Related]
52. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
[TBL] [Abstract][Full Text] [Related]
53. Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.
Goswami S; Yee SW; Stocker S; Mosley JD; Kubo M; Castro R; Mefford JA; Wen C; Liang X; Witte J; Brett C; Maeda S; Simpson MD; Hedderson MM; Davis RL; Roden DM; Giacomini KM; Savic RM
Clin Pharmacol Ther; 2014 Sep; 96(3):370-9. PubMed ID: 24853734
[TBL] [Abstract][Full Text] [Related]
54. Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients.
Moeez S; Khalid Z; Jalil F; Irfan M; Ismail M; Arif MA; Niazi R; Khalid S
J Pak Med Assoc; 2019 Feb; 69(2):155-163. PubMed ID: 30804576
[TBL] [Abstract][Full Text] [Related]
55. Metformin associated inflammation levels regulation in type 2 diabetes mellitus-tuberculosis coinfection patients - A case report.
Novita BD; Soediono EI; Nugraha J
Indian J Tuberc; 2018 Oct; 65(4):345-349. PubMed ID: 30522623
[TBL] [Abstract][Full Text] [Related]
56. [Results of combined therapy of stable 2-3 FC angina of effort with metabolic syndrome including metformin].
Dashdamirov RL
Klin Med (Mosk); 2014; 92(12):38-42. PubMed ID: 25980297
[TBL] [Abstract][Full Text] [Related]
57. [Circulating interleukin-16 in blood of patients with metabolic syndrome and type 2 diabetes mellitus].
Zak KP; Kondratskaia IN; Mel'nichenko SV; Popova VV
Lik Sprava; 2007; (5-6):46-9. PubMed ID: 18416164
[TBL] [Abstract][Full Text] [Related]
58. Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach.
Liu X; Gao J; Chen J; Wang Z; Shi Q; Man H; Guo S; Wang Y; Li Z; Wang W
Sci Rep; 2016 Jul; 6():30785. PubMed ID: 27470195
[TBL] [Abstract][Full Text] [Related]
59. The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects.
Khatami F; Mohajeri-Tehrani MR; Tavangar SM
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):719-731. PubMed ID: 31122183
[TBL] [Abstract][Full Text] [Related]
60. Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy.
Singh S; Shukla AK; Usman K; Banerjee M
Pharmacogenet Genomics; 2023 Apr; 33(3):51-58. PubMed ID: 36853844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
